Skip to content

Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle

Impact of Endometrial Compaction on Reproductive Outcomes After Cryotransfer of Euploid Embryos in a Natural Cycle: Prospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05960370
Acronym
Compaction
Enrollment
206
Registered
2023-07-25
Start date
2022-06-15
Completion date
2025-06-15
Last updated
2024-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Due to Nonimplantation

Brief summary

Multicenter prospective observational cohort study, comparing ongoing pregnancy rates in natural cycles for euploid embryo transfer in patients who present endometrial compaction at the time of the transfer versus those who have a stable or greater endometrial thickness with respect to the estrogenic phase.

Detailed description

Multicenter prospective observational cohort study. Based on our sample size calculation, the study group will consist of 206 women (exposed or compaction group: 103 women with a decrease of ≥ 5% in endometrial thickness between the estrogenic phase and the day of embryo transfer; non-exposed non-compaction group: 103 women with similar or greater endometrial thickness between these time points). The main objective of this study is to compare the ongoing pregnancy rates in natural cycles for euploid embryo transfer in patients who present endometrial compaction at the time of transfer versus those who with a stable or greater endometrial thickness with respect to the estrogenic phase. The estimated duration of the study is 24-30 months. Inclusion criteria are: 18 to 50 years of age, with primary or secondary infertility, subjected to endometrial preparation in a modified natural cycle for transfer of a genetically euploid blastocyst, from their own oocyte or oocyte donation, with a normal uterine cavity. Exclusion criteria are: uterine or endometrial disease (e.g., multiple myomatosis, severe adenomyosis, Asherman syndrome, refractory endometrium), conditions that prevent correct ultrasound assessment (tilted uterus), or a history of recurrent implantation failure or repeated miscarriages.

Interventions

OTHERObservational non intervention study

An additional control scan will be performed vaginally the day of the embryo transfer. Rest of follow up and treatment will be executed as usually.

Sponsors

Universidad Miguel Hernandez de Elche
CollaboratorOTHER
Instituto Bernabeu
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 to 50 years * Primary or secondary infertility * Normal uterine cavity * Endometrial preparation in a modified natural cycle for single embryo transfer * Embryo in blastocyst state from own oocyte or oocyte donation cycles, who had normal results on preimplantation genetic testing for aneuploidy (PGT-A) via trophectoderm biopsy.

Exclusion criteria

* Uterine or endometrial disease (multiple myomatosis \[\>3 fibroids of \> 3 cm\], adenomyosis, Asherman syndrome) * Difficulties in correctly measuring endometrial thickness due to a retroverted or tilted uterus * History of recurrent implantation failure (3 or more transferred blastocysts of good quality, from their own oocyte \[\<35 years\] or oocyte donation); recurrent early Pregnancy Loss (the loss of two or more pregnancies before 10 weeks of gestational age. * Suboptimal endometrial response (endometrium \< 6 mm on the day of ovulation triggering).

Design outcomes

Primary

MeasureTime frameDescription
Ongoing pregnancy rate8-10 weeks gestational age.Presence of an intrauterine pregnancy with positive embryo heartbeat as seen by sonography at 8-10 weeks gestational age.

Secondary

MeasureTime frameDescription
Biochemical pregnancy loss9-10 days after the embryo transfer.Spontaneous pregnancy demise based on decreasing serum b-hCG levels, without an ultrasound evaluation.
Clinical pregnancy5-6 weeks gestational age.A pregnancy diagnosed by ultrasonographic visualization of one or more gestational sacs or definitive clinical signs of pregnancy.
Ectopic pregnancy5-8 weeks gestational age.ultrasonic or surgical visualization of a pregnancy outside of the endometrial cavity.
Early pregnancy loss5-10 weeks gestational age.spontaneous pregnancy demise before 10 weeks of gestational age (before 8th developmental week).

Countries

Spain

Contacts

Primary ContactEsperanza E de la Torre Pérez, Gynecologist
espe_delatorre@hotmail.com+34625072082
Backup ContactJuan Carlos J Castillo Farfan, Doctor
jcastillo@institutobernabeu.com+34650562634

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026